sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Asia Pacific Nasal Delivery Devices Market...

Asia Pacific Nasal Delivery Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country

TIPRE00018196 | Pages: 148 | Medical Device | Jan 2021 | Type: Regional | Status: Published

Market Introduction

Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Nasal drug delivery is one of the efficient routes of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.


Get more information on this report :



Market Overview and Dynamics

The Asia Pacific nasal delivery devices market is expected to reach US$ 21,402.86 million in 2027 from US$ 12,418.34 million in 2019. The market is estimated to grow with a CAGR of 7.1% from 2020-2027. The growth of the market is attributed to some key driving factors such as the increasing development in healthcare infrastructure and the growing prevalence of diseases of central nervous system. However, the market growth is likely to be hindered owing to the issues regarding nasal delivery devices market.

Key Market Segments

Based on drug type, the nasal delivery devices market is anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. Based on delivery technologies, the nasal delivery devices market, is segmented into spray, nebulizers, inhalers, and others. Based on end user, the nasal delivery devices market, is segmented into home care settings, hospitals, and clinics.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources for nasal delivery devices market included in the report are Organization for Economic Co-operation and Development (OECD), Alzheimer’s and Related Disorders Society of India (ARDSI), and others.

Reasons to buy the report

  • To understand the Asia Pacific nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
  • Efficiently plan M&A and partnership deals in Asia Pacific nasal delivery devices market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region

 

ASIA PACIFIC NASAL DELIVERY DEVICES MARKET SEGMENTATION

By Drug Type

  • Anaesthetics
  • Antibiotics
  • Pain Relief Drugs
  • Calcium Supplements
  • Vasoconstrictors
  • Antihistamines
  • Others

By Delivery Technologies

  • Spray
  • Nebulizers
  • Inhalers
  • Others

By End User

  • Home Care Settings
  • Hospitals
  • Clinics

 

By Country

  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific

 

Company Profiles

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Reddy's Laboratories
 

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Nasal Delivery Devices Market – By Drug Type

1.3.2        Nasal Delivery Devices Market – By Delivery Technologies

1.3.3        Nasal Delivery Devices Market – By End User

1.3.4        Asia Pacific Nasal Delivery Devices Market – By Country

2.          Asia Pacific Nasal Delivery Devices Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Asia Pacific Nasal Delivery Devices Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Nasal Delivery Devices Market- Asia Pacific PEST Analysis

4.3        Expert Opinion

5.          Asia Pacific Nasal Delivery Devices Market - Key Market Dynamics

5.1        Market Drivers

5.1.1        Increasing Development in Healthcare Infrastructure

5.1.2        Growing Prevalence of Diseases of Central Nervous System

5.2        Market Restraints

5.2.1        Issues Regarding Nasal Delivery Devices Market

5.3        Market Opportunities

5.3.1        Increasing Participation by Market Players and Awareness Among People

5.4        Future Trends

5.4.1        High Growth in the Pharmaceutical Sector

5.5        Impact Analysis

6.          Nasal Delivery Devices Market – Asia Pacific Analysis

6.1        Asia Pacific Nasal Delivery Devices Market Revenue Forecasts and Analysis

7.          Asia Pacific Nasal Delivery Devices Market Analysis and Forecasts To 2027 – By Drug Type

7.1        Overview

7.2        Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)

7.3        Anaesthetics

7.3.1        Overview

7.3.2        Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.4        Antibiotics

7.4.1        Overview

7.4.2        Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.5        Pain Relief Drugs

7.5.1        Overview

7.5.2        Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.6        Calcium Supplements

7.6.1        Overview

7.6.2        Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.7        Vasoconstrictors

7.7.1        Overview

7.7.2        Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.8        Antihistamines

7.8.1        Overview

7.8.2        Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.9        Others

7.9.1        Overview

7.9.2        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.          Asia Pacific Nasal Delivery Devices Market Analysis – By Delivery Technologies

8.1        Overview

8.2        Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)

8.3        Spray

8.3.1        Overview

8.3.2        Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.4        Nebulizers

8.4.1        Overview

8.4.2        Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.5        Inhalers

8.5.1        Overview

8.5.2        Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.6        Others

8.6.1        Overview

8.6.2        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.          Asia Pacific Nasal Delivery Devices Market Analysis – By End-User

9.1        Overview

9.2        Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)

9.3        Home Care Settings

9.3.1        Overview

9.3.2        Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.4        Hospitals

9.4.1        Overview

9.4.2        Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.5        Clinics

9.5.1        Overview

9.5.2        Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

10.       Nasal Delivery Devices Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      Asia Pacific: Nasal Delivery Devices Market

10.1.1     Overview

10.1.1.1       Asia Pacific: Nasal Delivery Devices Market - Revenue and Forecast to 2027 (USD Million)

10.1.2     Asia Pacific: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)

10.1.3     Asia Pacific: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)

10.1.4     Asia Pacific: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)

10.1.5     Asia Pacific: Nasal Delivery Devices Market, by Country, 2018 & 2027 (%)

10.1.6     China: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1       China: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2       China: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)

10.1.6.3       China: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)

10.1.6.4       China: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)

10.1.7     Japan: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Japan: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Japan: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)

10.1.7.3       Japan: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)

10.1.7.4       Japan: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)

10.1.8     India: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       India: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       India: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)

10.1.8.3       India: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)

10.1.8.4       India: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)

10.1.9     South Korea: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       South Korea: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       South Korea: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)

10.1.9.3       South Korea: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)

10.1.9.4       South Korea: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)

10.1.10   Australia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    Australia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    Australia: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)

10.1.10.3    Australia: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)

10.1.10.4    Australia: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)

10.1.11   Rest of Asia-Pacific: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Rest of Asia-Pacific: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Rest of Asia-Pacific: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)

10.1.11.3    Rest of Asia-Pacific: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)

10.1.11.4    Rest of Asia-Pacific: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)

11.       Impact of COVID-19 Pandemic on Asia Pacific Nasal Delivery Devices Market

11.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.       COMPANY PROFILES

12.1      GlaxoSmithKline plc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      AstraZeneca

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Pfizer Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BD

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

13.       Appendix

13.1      About the Insight Partners

13.2      Glossary of terms

LIST OF TABLES

Table 1.            Asia Pacific Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 2.            Asia Pacific Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027  (USD Million)

Table 3.            Asia Pacific Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 4.            China Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 5.            China Nasal Delivery Devices Market, by Delivery Technologies– Revenue and Forecast to 2027 (USD Million)

Table 6.            China Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.            Japan Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 8.            Japan Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 9.            Japan Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          India Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          India Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 12.          India Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          South Korea Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          South Korea Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027  (USD Million)

Table 15.          South Korea Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Australia Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Australia Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027  (USD Million)

Table 18.          Australia Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          Rest of Asia-Pacific Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027  (USD Million)

Table 20.          Rest of Asia-Pacific Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 21.          Rest of Asia-Pacific Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 22.          Glossary of Terms, Nasal Delivery Devices Market

LIST OF FIGURES

Figure 1.           Nasal Delivery Devices Market Segmentation

Figure 2.           Asia Pacific Nasal Delivery Devices Market Overview

Figure 3.           Inhalers Segment Held Largest Share of Delivery Technologies in Nasal Delivery Devices Market

Figure 4.           China is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Nasal Delivery Devices Market - Asia Pacific PEST Analysis

Figure 6.           Nasal Delivery Devices Market Impact Analysis of Driver and Restraints

Figure 7.           Asia Pacific Nasal Delivery Devices Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)

Figure 9.           Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)

Figure 17.        Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)

Figure 22.        Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Asia Pacific: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)

Figure 26.        Asia Pacific Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)

Figure 27.        China: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Japan: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        India: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        South Korea: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Australia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Rest of Asia-Pacific: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

 

 

  1. GlaxoSmithKline plc.
  2. AstraZeneca
  3. Pfizer Inc.
  4. BD
  5. Sanofi
  6. Merck & Co., Inc.
  7. Cadila Pharmaceuticals Ltd.
  8. Novartis AG
  9. Dr. Reddy's Laboratories
  • To understand the Asia Pacific nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
  • Efficiently plan M&A and partnership deals in Asia Pacific nasal delivery devices market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription